Open an Account
search icon
4
NOTIFICATIONS
Best Algo trading app in India
Bigul

Medico Intercontinental Ltd - 539938 - Closure of Trading Window

 Dear Sir / Ma'am, Sub: Intimation of Closure of Trading Window for Designated persons and immediate relative of Designated Person. Pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015 and in compliance with circular no. LIST/COMP/01/2019-20 dated 2nd April, 2019 issued by BSE Limited, we wish to inform you that the 'Trading Window' for dealing in the securities of the Company has been closed and shall remain closed for all the designated persons and their immediate relatives till the conclusion of 48 hours after the declaration of financial results of the company for the quarter and year ended March 31, 2020. You are requested to disseminate the above information on your website.
30-03-2020
Bigul

Medico Intercontinental Ltd - 539938 - Submission Of Disclosure Under Regulation 29(2) Of SEBI (Substantial Acquisition Of Shares And Takeovers) Regulations, 2011.

 The Company has received disclosure dated 24th March, 2020 under Regulation 29(2) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011 from Mr. Jay Sharadkumar Shah, Chief Financial officer of the Company, being Person Acting in Concert in respect of acquisition of Shares of Medico Intercontinental Limited by way of open market purchase on 23rd March, 2020. Accordingly, we are enclosing herewith copy of the above disclosure. You are kindly requested to take the same on record.
24-03-2020
Bigul

Medico Intercontinental Ltd - 539938 - Submission Of Disclosure Under Regulation 7(2) Read With Regulation 6(2) Of SEBI (Prohibition Of Insider Trading) Regulations, 2015.

 The Company has received disclosure dated 24th March, 2020 under Regulation 7(2) read with Regulation 6(2) of SEBI (Prohibition of Insider Trading) Regulations, 2015 from Mr. Jay Sharadkumar Shah, Chief Financial Officer of the Company, being Person Acting in Concert (PAC) in respect of acquisition of Shares of Medico Intercontinental Limited by way of open market purchase on 23rd March, 2020. Accordingly, we are enclosing herewith copy of the above disclosure. You are kindly requested to take the same on record.
24-03-2020
Bigul

Medico Intercontinental Ltd - 539938 - Submission Of Disclosure Under Regulation 29(2) Of SEBI (Substantial Acquisition Of Shares And Takeovers) Regulations, 2011.

 The Company has received disclosure dated 24th March, 2020 under Regulation 29(2) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011 from Mr. Samir Dilipkumar Shah, Promoter and Managing Director of the Company, in respect of acquisition of Shares of Medico Intercontinental Limited by way of open market purchase on 23rd March, 2020. Accordingly, we are enclosing herewith copy of the above disclosure. You are kindly requested to take the same on record.
24-03-2020
Bigul

Medico Intercontinental Ltd - 539938 - Submission Of Disclosure Under Regulation 7(2) Read With Regulation 6(2) Of SEBI (Prohibition Of Insider Trading) Regulations, 2015.

 The Company has received disclosure dated 24th March, 2020 under Regulation 7(2) read with Regulation 6(2) of SEBI (Prohibition of Insider Trading) Regulations, 2015 from Mr. Samir Dilipkumar Shah, Promoter and Managing Director of the Company, in respect of acquisition of Shares of Medico Intercontinental Limited by way of open market purchase on 23rd March, 2020. Accordingly, we are enclosing herewith copy of the above disclosure. You are kindly requested to take the same on record.
24-03-2020
Bigul

Medico Intercontinental Ltd - 539938 - Submission Of Disclosure Under Regulation 29(2) Of SEBI (Substantial Acquisition Of Shares And Takeovers) Regulations, 2011.

 The Company has received disclosure dated 21st March, 2020 under Regulation 29(2) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011 from Mr. Jay Sharadkumar Shah, Chief Financial Officer of the Company, being Person Acting in Concert (PAC) in respect of acquisition of Shares of Medico Intercontinental Limited by way of open market purchase on 20th March, 2020. Accordingly, we are enclosing herewith copy of the above disclosure. You are kindly requested to take the same on record.
21-03-2020
Bigul

Medico Intercontinental Ltd - 539938 - Submission Of Disclosure Under Regulation 7(2) Read With Regulation 6(2) Of SEBI (Prohibition Of Insider Trading) Regulations, 2015.

 The Company has received disclosure dated 21st March, 2020 under Regulation 7(2) read with Regulation 6(2) of SEBI (Prohibition of Insider Trading) Regulations, 2015 from Mr. Jay Sharadkumar Shah, Chief Financial Officer of the Company, being Person Acting in Concert (PAC) in respect of acquisition of Shares of Medico Intercontinental Limited by way of open market purchase on 20th March, 2020. Accordingly, we are enclosing herewith copy of the above disclosure. You are kindly requested to take the same on record.
21-03-2020
Bigul

Medico Intercontinental Ltd - 539938 - Submission Of Disclosure Under Regulation 29(2) Of SEBI (Substantial Acquisition Of Shares And Takeovers) Regulations, 2011.

 The Company has received disclosure dated 21st March, 2020 under Regulation 29(2) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011 from Mr. Samir Dilipkumar Shah, Promoter and Managing Director of the Company, in respect of acquisition of Shares of Medico Intercontinental Limited by way of open market purchase on 20th March, 2020. Accordingly, we are enclosing herewith copy of the above disclosure. You are kindly requested to take the same on record.
21-03-2020
Bigul

Medico Intercontinental Ltd - 539938 - Submission Of Disclosure Under Regulation 7(2) Read With Regulation 6(2) Of SEBI (Prohibition Of Insider Trading) Regulations, 2015.

 The Company has received disclosure dated 21st March, 2020 under Regulation 7(2) read with Regulation 6(2) of SEBI (Prohibition of Insider Trading) Regulations, 2015 from Mr. Samir Dilipkumar Shah, Promoter and Managing Director of the Company, in respect of acquisition of Shares of Medico Intercontinental Limited by way of open market purchase on 20th March, 2020. Accordingly, we are enclosing herewith copy of the above disclosure. You are kindly requested to take the same on record.
21-03-2020
Bigul

Medico Intercontinental Ltd - 539938 - Submission Of Disclosure Under Regulation 29(2) Of SEBI (Substantial Acquisition Of Shares And Takeovers) Regulations, 2011.

 The Company has received disclosure dated 18th March, 2020 under Regulation 29(2) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011 from Mr. Samir Dilipkumar Shah, Promoter and Managing Director of the Company, in respect of acquisition of Shares of Medico Intercontinental Limited by way of open market purchase on 18th March, 2020. Accordingly, we are enclosing herewith copy of the above disclosure. You are kindly requested to take the same on record.
18-03-2020
Next Page
Close

Let's Open Free Demat Account